BG31070A3 - Метод за получаване на 11-дезокси-16-арил-сигма- тетранорпростагландини - Google Patents

Метод за получаване на 11-дезокси-16-арил-сигма- тетранорпростагландини

Info

Publication number
BG31070A3
BG31070A3 BG034499A BG3449976A BG31070A3 BG 31070 A3 BG31070 A3 BG 31070A3 BG 034499 A BG034499 A BG 034499A BG 3449976 A BG3449976 A BG 3449976A BG 31070 A3 BG31070 A3 BG 31070A3
Authority
BG
Bulgaria
Prior art keywords
tetranoprostagine
dexoxy
aryl
obtaining
16aryl
Prior art date
Application number
BG034499A
Other languages
English (en)
Inventor
James EGGLER
Jasjit Bindra
Hans-Jurgen Hess
Original Assignee
Неизвестен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Неизвестен filed Critical Неизвестен
Publication of BG31070A3 publication Critical patent/BG31070A3/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Метод за получаване на охарактеризирани и доказани в описанието оптично активни 11-дезокси-16арил-омега-тетранорпростагландини с формула.... Патентните претенции са формулирани в 1 точка.
BG034499A 1975-10-21 1976-10-21 Метод за получаване на 11-дезокси-16-арил-сигма- тетранорпростагландини BG31070A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/624,486 US3984400A (en) 1975-10-21 1975-10-21 11-Desoxy-16-aryl-ω-tetranorprostaglandins

Publications (1)

Publication Number Publication Date
BG31070A3 true BG31070A3 (bg) 1981-10-15

Family

ID=24502191

Family Applications (1)

Application Number Title Priority Date Filing Date
BG034499A BG31070A3 (bg) 1975-10-21 1976-10-21 Метод за получаване на 11-дезокси-16-арил-сигма- тетранорпростагландини

Country Status (30)

Country Link
US (1) US3984400A (bg)
JP (2) JPS5251353A (bg)
AR (1) AR213831A1 (bg)
AT (1) AT360673B (bg)
BE (1) BE847447A (bg)
BG (1) BG31070A3 (bg)
CA (1) CA1092103A (bg)
CH (1) CH619930A5 (bg)
CS (2) CS191321B2 (bg)
DD (1) DD128590A5 (bg)
DE (1) DE2646878A1 (bg)
DK (1) DK472976A (bg)
ES (1) ES452538A1 (bg)
FI (1) FI762990A (bg)
GB (1) GB1520958A (bg)
GR (1) GR63621B (bg)
HU (1) HU175022B (bg)
IE (1) IE44016B1 (bg)
IL (1) IL50657A (bg)
LU (1) LU76045A1 (bg)
NL (1) NL163780C (bg)
NO (1) NO763451L (bg)
NZ (1) NZ182297A (bg)
PH (1) PH11472A (bg)
PL (1) PL112539B1 (bg)
PT (1) PT65727B (bg)
RO (1) RO71900A (bg)
SE (1) SE7610995L (bg)
SU (2) SU727139A3 (bg)
ZA (1) ZA766204B (bg)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4365077A (en) * 1975-06-23 1982-12-21 Pfizer Inc. 11-Desoxy-16-aryloxy-ω-tetranorprostaglandins
ZA77160B (en) * 1976-02-13 1977-11-30 Upjohn Co Prostaglandin analogs
US4140721A (en) * 1976-07-26 1979-02-20 The Upjohn Company 2-Decarboxy-2-hydroxymethyl-13,14-didehydro-17-phenyl-PGA, PGD and PGE compounds
US4058564A (en) * 1976-07-26 1977-11-15 The Upjohn Company Aliphatic 2-decarboxy-2-hydroxymethyl-13,14-didehydro-PG compounds
US4177346A (en) * 1976-08-06 1979-12-04 Pfizer Inc. 1,5-Disubstituted-2-pyrrolidones
JPS6210843Y2 (bg) * 1981-01-23 1987-03-14
JPS59190734U (ja) * 1983-06-06 1984-12-18 庄田商事株式会社 薄板用連続送り装置
US4576962A (en) * 1983-10-19 1986-03-18 The Procter & Gamble Company Prostaglandin analogues
US4883614A (en) * 1984-07-27 1989-11-28 Hoffman-La Roche Inc. Phenyl substituted-2,4,6,8-nonatetraenoic acid
US4780251A (en) * 1984-07-27 1988-10-25 Hoffman-La Roche Inc. Phenyl substituted-2,4,6,8-nonatetraenoic acid
US9872864B2 (en) 2011-08-12 2018-01-23 Ascendis Pharma A/S Sustained release composition of prostacyclin
US10544915B2 (en) * 2017-04-27 2020-01-28 Valeo North America, Inc. Vehicle lamp assembly having an improved heat sink with light shield

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840573A (en) * 1970-12-21 1974-10-08 Searle & Co 2-(3-hydroxy-3-optionally alkylated-1-alkynyl)-3-hydroxy-5-oxygenated cyclopent-1-enealkanoic acids,optical isomers thereof and esters corresponding
US3932389A (en) * 1974-12-11 1976-01-13 Pfizer Inc. 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins

Also Published As

Publication number Publication date
PL193183A1 (pl) 1978-03-28
DE2646878A1 (de) 1977-05-05
ZA766204B (en) 1977-09-28
PT65727B (en) 1978-04-18
CA1092103A (en) 1980-12-23
JPS5251353A (en) 1977-04-25
IE44016B1 (en) 1981-07-29
NZ182297A (en) 1978-09-25
GB1520958A (en) 1978-08-09
AT360673B (de) 1981-01-26
NO763451L (bg) 1977-04-22
NL7611660A (nl) 1977-04-25
CH619930A5 (bg) 1980-10-31
CS191321B2 (en) 1979-06-29
JPS5531153B2 (bg) 1980-08-15
NL163780C (nl) 1980-10-15
SU900806A3 (ru) 1982-01-23
NL163780B (nl) 1980-05-16
DD128590A5 (de) 1977-11-30
PT65727A (en) 1976-11-01
FI762990A (bg) 1977-04-22
SE7610995L (sv) 1977-04-22
IL50657A0 (en) 1976-12-31
IE44016L (en) 1977-04-21
ES452538A1 (es) 1977-11-01
AR213831A1 (es) 1979-03-30
LU76045A1 (bg) 1977-05-31
DK472976A (da) 1977-04-22
CS191343B2 (en) 1979-06-29
RO71900A (ro) 1981-05-30
IL50657A (en) 1980-05-30
JPS5490168A (en) 1979-07-17
HU175022B (hu) 1980-04-28
PH11472A (en) 1978-02-01
ATA785876A (de) 1980-06-15
BE847447A (fr) 1977-04-20
GR63621B (en) 1979-11-27
SU727139A3 (ru) 1980-04-05
AU1873776A (en) 1978-02-16
PL112539B1 (en) 1980-10-31
US3984400A (en) 1976-10-05

Similar Documents

Publication Publication Date Title
BG28065A4 (bg) Метод за получаване на 2-фенил-3-арилбензотиофели
BG31497A3 (bg) Метод за получаване на 4-амино-5-алкил-сулфонил ортонизамиди
BG38164A3 (bg) Метод за получаване на n- заместени-4-пипериданамини
BG31645A3 (bg) Метод за получаване на фенетаноламини
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG28411A4 (bg) Метод за получаване на оптично активни норпиненови съединения
BG33153A3 (bg) Метод за получаване на 1-арилокси-2-хидрокси-3-алкиленаминопропани
BG27905A3 (bg) Метод за получаване на фосфонисти киселини
BG36197A3 (bg) Метод за производство на инданилови производни
BG31070A3 (bg) Метод за получаване на 11-дезокси-16-арил-сигма- тетранорпростагландини
BG28072A4 (bg) Метод за получаване на 1 n заместени канамицинови производни
BG30778A3 (bg) Метод за получаване на ебурнаменинови производни
BG34038A3 (bg) Метод за получаване на 7-заместени амино-ацетамидо оксадетиа-цефалоспорини
BG31073A3 (bg) Метод за получаване на 1,5-заместени-2-пиролидони
BG30175A4 (bg) Метод за получаване на пиридонови съединения
BG31504A3 (bg) Метод за получаване на депостероидни естери
BG30927A3 (bg) Метод за получаване на транс-4-алфа-фенил-октахидро-1н-2 пиридини
BG30021A3 (bg) Метод за получаване на имидазоизохинолин-диони
BG28574A3 (bg) Метод за получаване на 4 дифенилметилен 1 хидрокси бензол пиперидини
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони
BG28264A3 (bg) Метод за получаване на кортикоиди
BG28845A3 (bg) Метод за получаване на n-алкилдифениламини
BG32117A4 (bg) Метод за получаване олеандомицини
BG28066A3 (bg) Метод за получаване на пиридобензодиазепинони
BG33283A3 (bg) Метод за получаване на пиридазинилхидразони